“Placebo- Controlled Trial of Pharmaceutical Optimized Lisinopril 10mg (F-5) in Patients With Essential Hypertension for Efficacy & Biochemical Evaluation”. 2024. Medical Forum Monthly 25 (12). http://medicalforummonthly.com/index.php/mfm/article/view/2376.